Literature DB >> 3652034

Expression of c-myb protooncogene and other cell cycle-related genes in normal and neoplastic human colonic mucosa.

G Torelli1, D Venturelli, A Coló, C Zanni, L Selleri, L Moretti, B Calabretta, U Torelli.   

Abstract

The expression of c-myb, c-myc, histone H3, and ornithine decarboxylase genes was examined by Northern blot analysis in the normal and neoplastic mucosa of ten subjects affected by colon cancer. The mRNA levels of c-myb protooncogene were detected at low levels in all normal samples but were increased in the neoplastic mucosa of six cases in comparison to the normal counterpart. In five of these six cases the mRNA levels of c-myc, histone H3, and ornithine decarboxylase mRNAs were also increased, suggesting that there is a relation between the high expression of c-myb and the fraction of cycling neoplastic cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3652034

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  19 in total

1.  Functional analysis of c-Myb protein in T-lymphocytic cell lines shows that it trans-activates the c-myc promoter.

Authors:  J L Evans; T L Moore; W M Kuehl; T Bender; J P Ting
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

Review 2.  Calcium, a Cell Cycle Commander, Drives Colon Cancer Cell Diffpoptosis.

Authors:  Ahmed A Abd-Rabou
Journal:  Indian J Clin Biochem       Date:  2016-03-30

Review 3.  Transcriptional regulation during myelopoiesis.

Authors:  N Lenny; J J Westendorf; S W Hiebert
Journal:  Mol Biol Rep       Date:  1997-08       Impact factor: 2.316

4.  Transcriptional trans-repression by the c-myb proto-oncogene product.

Authors:  H Nakagoshi; T Nagase; Y Ueno; S Ishii
Journal:  Nucleic Acids Res       Date:  1989-09-25       Impact factor: 16.971

5.  c-myc overexpression is a tumor-specific phenomenon in a subset of human colorectal carcinomas.

Authors:  A Viel; R Maestro; G Toffoli; G Grion; M Boiocchi
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

6.  MYB regulates the DNA damage response and components of the homology-directed repair pathway in human estrogen receptor-positive breast cancer cells.

Authors:  Ren-Ming Yang; Devathri Nanayakkara; Murugan Kalimutho; Partha Mitra; Kum Kum Khanna; Eloise Dray; Thomas J Gonda
Journal:  Oncogene       Date:  2019-04-10       Impact factor: 9.867

7.  Myb overexpression overrides androgen depletion-induced cell cycle arrest and apoptosis in prostate cancer cells, and confers aggressive malignant traits: potential role in castration resistance.

Authors:  Sanjeev K Srivastava; Arun Bhardwaj; Seema Singh; Sumit Arora; Steven McClellan; William E Grizzle; Eddie Reed; Ajay P Singh
Journal:  Carcinogenesis       Date:  2012-03-19       Impact factor: 4.944

8.  c-Myb and Bcl-x overexpression predicts poor prognosis in colorectal cancer: clinical and experimental findings.

Authors:  A Biroccio; B Benassi; I D'Agnano; C D'Angelo; S Buglioni; M Mottolese; A Ricciotti; G Citro; M Cosimelli; R G Ramsay; B Calabretta; G Zupi
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

9.  Overexpression of c-Myb is associated with suppression of distant metastases in colorectal carcinoma.

Authors:  Michal Tichý; Lucia Knopfová; Jiří Jarkovský; Lucie Pekarčíková; Lenka Veverková; Petr Vlček; Jana Katolická; Ivan Čapov; Markéta Hermanová; Jan Šmarda; Petr Beneš
Journal:  Tumour Biol       Date:  2016-02-12

10.  MYB suppresses differentiation and apoptosis of human breast cancer cells.

Authors:  Yvette Drabsch; Ramsay G Robert; Thomas J Gonda
Journal:  Breast Cancer Res       Date:  2010-07-26       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.